Drug Eluting Balloon Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Drug Eluting Balloon Market is segmented by Product (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon, Others (Renal/Urology)), Technology, End-User and Geography

Drug Eluting Balloon Market Snapshot

Drug Eluting Balloon Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 18 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The drug eluting balloon market is projected to grow with an approximate CAGR of 18%, during the forecast period. The increasing incidence of coronary and peripheral artery diseases around the world is expected to boost market growth. In addition, an increase in research and development supported by government and private institutions and continuous initiatives on awareness regarding heart diseases are fuelling the market growth.

According to the World Health Organization (WHO), every year 31% of world deaths (17.9 million) are caused by cardiovascular diseases. Increasing geriatric population, which is prone to cardiovascular diseases and growing healthcare spending is projected to bolster the market growth. However, the high cost of development and commercialization of drug eluting balloons coupled with stringent regulatory procedures are hampering the market growth.

Scope of the Report

Drug eluting balloons are semi-compliant angioplasty balloons that are used to elute the drug in the targeted vessel. The drug eluting balloons may be coated or non-coated. The report covers drug eluting balloons that are used to treat coronary, peripheral or other (renal/Urology) indications.

By Product
Coronary Drug Eluting Balloon
Peripheral Drug Eluting Balloon
Others (Renal/Urology)
By Technology
By End-User
Ambulatory Surgical Centers
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Coronary Drug Eluting Balloons are Expected to Grow at Healthy Rate

  • Drug eluting balloons play an important role in the treatment of coronary artery diseases. Growing prevalence of coronary artery diseases coupled with increasing geriatric population is expected to boost the segment growth.
  • According to the British Heart Foundation, in 2016 Coronary Artery Diseases are leading cause of death worldwide.
  • Peripheral drug eluting balloons segment is projected to have significant share owing to the increased usage of drug eluting balloons in treatment of peripheral artery diseases and growing R&D in expanding the indications, new product launches in the peripheral artery segment.
  • Furthermore, the anticipated product launches coupled with the development of innovative coating and balloon technologies expected to boost the market growth over the forecast period.
Drug Eluting Balloons Market

North America is Expected to Have Significant Market Share

The factors such as the increasing prevalence of coronary artery diseases in the region. Furthermore, increasing obesity, which develops further cardiovascular diseases coupled with a sedentary lifestyle in the region expected to boost regional growth. According to Center for Disease Control and Prevention (CDC), in 2017, coronary heart disease killed about 365,914 people in the United States and about 20% of CAD deaths happen in people less than 65 years old. Owing to the presence of a large pool of people with heart diseases, growing healthcare spending especially in emerging countries of Asia expected to boost the market growth in the Asia-Pacific Region. Moreover, new product launches companies expanding into emerging Asian Countries projected to bolster the regional growth over the forecast period.

Drug Eluting Balloon Market -  Growth Rate by Region - Image

Competitive Landscape

Drug eluting balloon market is moderately consolidated and competitive. Companies are focusing on innovating the balloon technologies, expanding product indications and regions to expand their market share. For instance, in Feb 2019, MedAlliance S.A has received  breakthrough device designation for its sirolimus drug-eluting balloon SELUTION. The key market players operating in the drug eluting balloon market include Medtronic Plc, Boston Scientific Corporation, Becton, Dickson and Company, Terumo Corporation, and Koninklijke Philips N.V. among others.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Prevalence of Peripheral and Coronary Artery Diseases

      2. 4.2.2 Rising Geriatric Population, leading to Cardiovascular Diseases

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Development and Commercialization of Drug Eluting Balloons

      2. 4.3.2 Adverse Effects and Product Recalls

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Coronary Drug Eluting Balloon

      2. 5.1.2 Peripheral Drug Eluting Balloon

      3. 5.1.3 Others (Renal/Urology)

    2. 5.2 By Technology

      1. 5.2.1 FreePac

      2. 5.2.2 TransPac

      3. 5.2.3 EnduraCoat

      4. 5.2.4 Others

    3. 5.3 By End-User

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Surgical Centers

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Medtronic Plc

      2. 6.1.2 Boston Scientific Corporation

      3. 6.1.3 Becton, Dickson and Company

      4. 6.1.4 Terumo Corporation

      5. 6.1.5 Koninklijke Philips N.V.

      6. 6.1.6 Cook Group Incorporated

      7. 6.1.7 Biotronik

      8. 6.1.8 B. Braun Melsungen AG

      9. 6.1.9 SurModics, Inc.

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Drug Eluting Balloon Market market is studied from 2018 - 2026.

The Drug Eluting Balloon Market is growing at a CAGR of 18% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Medtronic Plc, Boston Scientific Corporation, Becton, Dickson and Company, Terumo Corporation, Koninklijke Philips N.V. are the major companies operating in Drug Eluting Balloon Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!